e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Animal models of asthma and lung inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma
J. Siegle, N. Hansbro, C. Dong, P. Angkasekwinai, P. Foster, R. Kumar (Sydney, Newcastle, Australia; Houston, United States Of America; Pathumthani, Thailand)
Source:
Annual Congress 2010 - Animal models of asthma and lung inflammation
Session:
Animal models of asthma and lung inflammation
Session type:
Thematic Poster Session
Number:
1342
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Siegle, N. Hansbro, C. Dong, P. Angkasekwinai, P. Foster, R. Kumar (Sydney, Newcastle, Australia; Houston, United States Of America; Pathumthani, Thailand). Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma. Eur Respir J 2010; 36: Suppl. 54, 1342
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Role of CD163 in human fatal asthma and murine asthma model.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "
in vitro
" models
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Aerobic training decreases epithelial expression of Th
2
cytokines in a murine model of allergic lung inflammation
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Year: 2007
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Year: 2019
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Decreased Smad7 expression in the airways of a mouse model of chronic asthma
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004
Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
CpG oligodeoxynucleotide treatment prevents the development of airway remodelling in a murine model of chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 2s
Year: 2002
IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005
MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production
in vitro
and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma
in vivo
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept